Neuer JAK1-Hemmer Upadacitinib wirkt auch bei Versagen anderer DMARDs
Crossref DOI link: https://doi.org/10.1007/s15002-018-1433-2
Published Online: 2018-10-08
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schumacher, Beate
Text and Data Mining valid from 2018-10-01
Article History
First Online: 8 October 2018